CL 22 (Fenofibrate (Micronized) 67 mg)
Pill with imprint CL 22 is White, Capsule-shape and has been identified as Fenofibrate (Micronized) 67 mg. It is supplied by Alvogen, Inc..
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 67 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CL 22
Fenofibrate (Micronized)
- Imprint:
- CL 22
- Strength:
- 67 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Alvogen, Inc.
- National Drug Code (NDC):
- 47781-0518
More about fenofibrate
- Fenofibrate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 41 Reviews
- Drug class: fibric acid derivatives
Consumer resources
- Fenofibrate
- Fenofibrate and Derivatives Tablets
- Fenofibrate and Derivatives Capsules
- Fenofibrate (Advanced Reading)
Other brands: TriCor, Lofibra, Antara, Lipofen, ... +2 more
Professional resources
- Fenofibric Acid/Fenofibrate (AHFS Monograph)
- Fenofibrate Capsules (FDA)
- Fenofibrate and Derivatives (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
